Person-Centered Care for Improving Quality of Life
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a person-centered approach (person-centered model-of-care) can improve the quality of life for breast cancer patients undergoing radiation therapy. Participants will either attend a 30-minute education session with a radiation therapist or receive the usual care. The study will compare these two groups to assess whether the additional support makes a difference. It is open to individuals with non-metastatic breast cancer who plan to start radiation therapy. Participants must communicate in English and have not yet begun any radiation therapy procedures. As an unphased trial, this study offers a unique opportunity to contribute to research that may enhance patient care and support during radiation therapy.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that the person-centered model-of-care is safe?
Research shows that person-centered care, like the approach tested in this trial, is generally safe. Studies have found that this method can enhance emotional well-being and increase patient satisfaction. No major safety concerns exist with person-centered care, as it primarily involves providing additional education and support. This care focuses on individual patient needs and preferences, aiming to improve the overall healthcare experience without altering the medical treatment itself. Consequently, it is well-tolerated and considered safe for patients.12345
Why are researchers excited about this trial?
Researchers are excited about the person-centered model-of-care because it aims to enhance patients' quality of life during radiation therapy. Unlike the standard approach, which strictly focuses on administering radiation, this model includes a 30-minute educational session with a radiation therapist. This interactive session is designed to empower patients by increasing their understanding of the treatment process, potentially reducing anxiety and improving overall satisfaction. By integrating personalized education, this approach could lead to a more holistic treatment experience for patients undergoing radiation therapy.
What evidence suggests that the person-centered model-of-care could improve quality of life for breast cancer patients receiving radiation therapy?
Research has shown that person-centered care can enhance patients' emotional well-being and satisfaction. In this trial, participants in the person-centered model-of-care arm will receive a 30-minute education session with a radiation therapist, in addition to standard radiation therapy procedures. Studies have found that this type of care often empowers patients and involves them more in their treatment choices. This approach is also cost-effective, providing good value for the benefits it offers. Patients frequently report feeling respected and well-informed, which enhances their overall experience. Overall, evidence suggests that person-centered care can lead to better outcomes compared to standard care practices.12678
Are You a Good Fit for This Trial?
This trial is for adults over 18 with non-metastatic breast cancer who speak English and can consent to treatment. They should be set to receive radiation therapy but haven't started any specific procedures or received previous radiation.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Radiation Therapy
Participants receive radiation therapy as per standard of care, with an additional 30-minute education session for those in the person-centered model
Follow-up
Participants are monitored for patient-reported outcomes such as anxiety levels, engagement, and preparedness for radiation therapy
What Are the Treatments Tested in This Trial?
Interventions
- Person-centered model-of-care
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Health Network, Toronto
Lead Sponsor